Terms: = Endocrine gland cancer AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521
540 results:
1. Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (pgls): results from a single institutional retrospective analysis.
Rubino M; Di Stasio GD; Bodei L; Papi S; Rocca PA; Ferrari ME; Fodor CI; Bagnardi V; Frassoni S; Mei R; Fazio N; Ceci F; Grana CM
Endocrine; 2024 May; 84(2):704-710. PubMed ID: 38324106
[TBL] [Abstract] [Full Text] [Related]
2. Ectopic pheochromocytomas in the third trimester: A case report and literature review.
Zhao L; Chen M; Chen X; Yu L; Du SG; Gan Q; Yang WZ; Jiang C; Xiao M
Medicine (Baltimore); 2024 Feb; 103(5):e36127. PubMed ID: 38306535
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paraganglioma.
Park YG; Park I; Kim Y; Lee HS; Lee W; Yoon S; Lee JL
Clin Genitourin Cancer; 2024 Apr; 22(2):413-419. PubMed ID: 38228412
[TBL] [Abstract] [Full Text] [Related]
4. EPAS1-mutated paragangliomas associated with haemoglobin disorders.
Mancini M; Buffet A; Porte B; Amar L; Lussey-Lepoutre C; Crinière L; Baudin E; Meatchi T; Gimenez-Roqueplo AP; Favier J; Burnichon N
Br J Haematol; 2024 Mar; 204(3):1054-1060. PubMed ID: 38195958
[TBL] [Abstract] [Full Text] [Related]
5. Animal and Cell Culture Models of Ppgls - Achievements and Limitations.
Karna B; Pellegata NS; Mohr H
Horm Metab Res; 2024 Jan; 56(1):51-64. PubMed ID: 38171372
[TBL] [Abstract] [Full Text] [Related]
6. An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline
Alzahrani AS; Bin Nafisah A; Alswailem M; Moria Y; Poprawski D; Al-Hindi H; Pacak K
Front Endocrinol (Lausanne); 2023; 14():1273093. PubMed ID: 38152133
[TBL] [Abstract] [Full Text] [Related]
7. Genotype-phenotype correlations in paediatric and adolescent phaeochromocytoma and paraganglioma: a cross-sectional study.
Seabrook A; Vasudevan A; Neville K; Gerstl B; Benn D; Smith J; Kirk J; Gill A; Clifton-Bligh R; Tucker K
Arch Dis Child; 2024 Feb; 109(3):201-208. PubMed ID: 38071512
[TBL] [Abstract] [Full Text] [Related]
8. Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.
Li M; Richter S; Mohr H; Drukewitz S; Poser I; Stanke D; Calsina B; Martinez-Montes AM; Quinkler M; Timmers HJLM; Nölting S; Beuschlein F; Remde H; Opocher G; Rapizzi E; Pacak K; Pamporaki C; Robledo M; Liu L; Jiang J; Bornstein SR; Eisenhofer G; Fliedner SMJ; Bechmann N
Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37902037
[TBL] [Abstract] [Full Text] [Related]
9. Prospective Validation of ThyroSPEC Molecular Testing of Indeterminate Thyroid Nodule Cytology Following Diagnostic Pathway Optimization.
Stewardson P; Eszlinger M; Wu J; Khalil M; Box A; Perizzolo M; Punjwani Z; Ziehr B; Sanyal R; Demetrick DJ; Paschke R
Thyroid; 2023 Dec; 33(12):1423-1433. PubMed ID: 37742115
[No Abstract] [Full Text] [Related]
10. Pheochromocytoma and paraganglioma in children and adolescents.
Stachowicz-Stencel T; Pasikowska N; Synakiewicz A
Acta Biochim Pol; 2023 Sep; 70(3):487-493. PubMed ID: 37717273
[TBL] [Abstract] [Full Text] [Related]
11. Visual analytics identifies key miRNAs for differentiating peripancreatic paraganglioma and pancreatic neuroendocrine tumors.
Enguita JM; Díaz I; García D; Cubiella T; Chiara MD; Valdés N
Front Endocrinol (Lausanne); 2023; 14():1162725. PubMed ID: 37383401
[TBL] [Abstract] [Full Text] [Related]
12. Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study.
De Filpo G; Parenti G; Sparano C; Rastrelli G; Rapizzi E; Martinelli S; Amore F; Badii B; Paolo P; Ercolino T; Mannelli M; Maggi M; Canu L
World J Surg Oncol; 2023 Jun; 21(1):192. PubMed ID: 37370080
[TBL] [Abstract] [Full Text] [Related]
13. Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review.
Wang X; Zhao Y; Liao Z; Zhang Y
Front Endocrinol (Lausanne); 2023; 14():1129622. PubMed ID: 37152961
[TBL] [Abstract] [Full Text] [Related]
14. Surgical and postsurgical management of abdominal paragangliomas and pheochromocytomas.
Araujo-Castro M; Pascual-Corrales E; Lorca Álvaro J; Mínguez Ojeda C; Pian H; Ruz-Caracuel I; Sanjuanbenito Dehesa A; Serrano Romero AB; Alonso-Gordoa T; Molina-Cerrillo J; Gómez Dos Santos V
Actas Urol Esp (Engl Ed); 2023 Mar; 47(2):68-77. PubMed ID: 37078847
[TBL] [Abstract] [Full Text] [Related]
15. Domain landscapes of somatic NF1 mutations in pheochromocytoma and paraganglioma.
Tabebi M; Frikha F; Volpe M; Gimm O; Söderkvist P
Gene; 2023 Jul; 872():147432. PubMed ID: 37062455
[TBL] [Abstract] [Full Text] [Related]
16. Tumour microenvironment in pheochromocytoma and paraganglioma.
Martinelli S; Amore F; Canu L; Maggi M; Rapizzi E
Front Endocrinol (Lausanne); 2023; 14():1137456. PubMed ID: 37033265
[TBL] [Abstract] [Full Text] [Related]
17. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline sdhd pathogenic variants.
Taïeb D; Wanna GB; Ahmad M; Lussey-Lepoutre C; Perrier ND; Nölting S; Amar L; Timmers HJLM; Schwam ZG; Estrera AL; Lim M; Pollom EL; Vitzthum L; Bourdeau I; Casey RT; Castinetti F; Clifton-Bligh R; Corssmit EPM; de Krijger RR; Del Rivero J; Eisenhofer G; Ghayee HK; Gimenez-Roqueplo AP; Grossman A; Imperiale A; Jansen JC; Jha A; Kerstens MN; Kunst HPM; Liu JK; Maher ER; Marchioni D; Mercado-Asis LB; Mete O; Naruse M; Nilubol N; Pandit-Taskar N; Sebag F; Tanabe A; Widimsky J; Meuter L; Lenders JWM; Pacak K
Lancet Diabetes Endocrinol; 2023 May; 11(5):345-361. PubMed ID: 37011647
[TBL] [Abstract] [Full Text] [Related]
18. SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis.
Su T; Yang Y; Jiang L; Xie J; Zhong X; Wu L; Jiang Y; Zhang C; Zhou W; Ye L; Ning G; Wang W
Front Endocrinol (Lausanne); 2023; 14():1121397. PubMed ID: 37008946
[TBL] [Abstract] [Full Text] [Related]
19. Pituitary tumours: molecular and genetic aspects.
De Sousa SMC; Lenders NF; Lamb LS; Inder WJ; McCormack A
J Endocrinol; 2023 Jun; 257(3):. PubMed ID: 36951812
[TBL] [Abstract] [Full Text] [Related]
20. Abdominal nonfunctional paraganglioma in which succinate dehydrogenase subunit B (SDHB) immunostaining was performed: a case report.
Tanaka T; Joraku A; Ishibashi S; Endo K; Emura M; Kikuchi Y; Shikama A; Kimura N; Shimazui T
J Med Case Rep; 2023 Mar; 17(1):106. PubMed ID: 36945070
[TBL] [Abstract] [Full Text] [Related]
[Next]
